[EN] NOVEL ARYL FRUCTOSE-1,6-BISPHOSPHATASE INHIBITORS<br/>[FR] NOUVEAUX INHIBITEURS DE LA FRUCTOSE-1,6-BIOPHOSPHATASE, A BASE D'ARYLE
申请人:METABASIS THERAPEUTICS INC
公开号:WO2001066553A2
公开(公告)日:2001-09-13
Novel FBPase inhibitors of formula (I) are useful in the treatment of diabetes and other conditions associated with elevated blood glucose.